Arc­turus teas­es da­ta from small tri­al of in­hal­able cys­tic fi­bro­sis mR­NA ther­a­py, stock rock­ets 

Arc­turus Ther­a­peu­tics has of­fered an ear­ly snap­shot of its in­haled mR­NA ther­a­py’s ef­fects in cys­tic fi­bro­sis, build­ing its case for a de­liv­ery tech­nol­o­gy de­signed to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER